Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097771 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marika A Franczak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical University of Gdansk, 80-210 Gdańsk, Poland. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Mesothelioma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Italian Association for Cancer Research, Law Offices of Peter G. Angelos Grant' from the Mesothelioma Applied Research Foundation.
Abstract (Originalsprache)
Malignant mesothelioma (MM) is a highly aggressive and resistant tumor. The prognostic role of key effectors of glycolytic metabolism in MM prompted our studies on the cytotoxicity of new inhibitors of glucose transporter type 1 (GLUT-1) and lactate dehydrogenase-A (LDH-A) in relation to ATP/NAD+ metabolism, glycolysis and mitochondrial respiration. The antiproliferative activity of GLUT-1 (PGL13, PGL14) and LDH-A (NHI-1, NHI-2) inhibitors, alone and in combination, were tested with the sulforhodamine-B assay in peritoneal (MESO-II, STO) and pleural (NCI-H2052 and NCI-H28) MM and non-cancerous (HMEC-1) cells. Effects on energy metabolism were measured by both analysis of nucleotides using RP-HPLC and evaluation of glycolysis and respiration parameters using a Seahorse Analyzer system. All compounds reduced the growth of MM cells in the µmolar range. Interestingly, in H2052 cells, PGL14 decreased ATP concentration from 37 to 23 and NAD+ from 6.5 to 2.3 nmol/mg protein. NHI-2 reduced the ATP/ADP ratio by 76%. The metabolic effects of the inhibitors were stronger in pleural MM and in combination, while in HMEC-1 ATP reduction was 10% lower compared to that of the H2052 cells, and we observed a minor influence on mitochondrial respiration. To conclude, both inhibitors showed cytotoxicity in MM cells, associated with a decrease in ATP and NAD+, and were synergistic in the cells with the highest metabolic modulation. This underlines cellular energy metabolism as a potential target for combined treatments in selected cases of MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Medical University of Gdansk, 80-210 Gdańsk, Poland.
- Department of Medical Oncology, Amsterdam University Medical Centers, Location VUmc, Cancer Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
- Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
- Dipartimento di Farmacia, Università di Pisa, 56126 Pisa, Italy.
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 91886-17871, Iran.
- Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad 91886-17871, Iran.
ORCID-Profile: Marika A Franczak, Oliwia Krol, Gabriela Harasim, Agata Jedrzejewska, Nadia Zaffaroni, Carlotta Granchi, Filippo Minutolo, Amir Avan, Elisa Giovannetti, Ryszard T Smolenski, Godefridus J Peters
Förderung
- National Science Center
- Italian Association for Cancer Research
- Law Offices of Peter G. Angelos Grant' from the Mesothelioma Applied Research Foundation
- National Science Center of Poland
- Law Offices of Peter G. Angelos Grant
- Mesothelioma Applied Research Foundation (MARF)
- Purine and Pyrimidine Society (MAF)
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Franczak, M. A., Krol, O., Harasim, G., Jedrzejewska, A., Zaffaroni, N., Granchi, C., Minutolo, F., Avan, A., Giovannetti, E., Smolenski, R. T., & Peters, G. J. (2023). Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097771
Vancouver
Franczak MA, Krol O, Harasim G, Jedrzejewska A, Zaffaroni N, Granchi C, et al. Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097771
BibTeX
@article{Franczak2023,
author = {Franczak, Marika A and Krol, Oliwia and Harasim, Gabriela and Jedrzejewska, Agata and Zaffaroni, Nadia and Granchi, Carlotta and Minutolo, Filippo and Avan, Amir and Giovannetti, Elisa and Smolenski, Ryszard T and Peters, Godefridus J},
title = {Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097771}
}
EUVIMED